VKTX
USDViking Therapeutics Inc. Common Stock
السعر في الوقت الحقيقي
مخطط الأسعار
المقاييس الرئيسية
مقاييس السوق
الافتتاح
$36.740
الأعلى
$38.000
الأدنى
$34.615
الحجم
3.77M
أساسيات الشركة
القيمة السوقية
3.9B
الصناعة
التكنولوجيا الحيوية
البلد
United States
إحصاءات التداول
متوسط الحجم
6.60M
البورصة
NCM
العملة
USD
نطاق 52 أسبوعاً
أخبار ذات صلة
Metsera the US obesity biotech at centre of Novo, Pfizer bidding war
Metsera has become the obesity drug market's hottest ticket.
Canaccord Genuity Initiates Coverage On Viking Therapeutics with Buy Rating, Announces Price Target of $106
Canaccord Genuity analyst Edward Nash initiates coverage on Viking Therapeutics with a Buy rating and announces Price Target of $106.
JP Morgan Maintains Overweight on Viking Therapeutics, Lowers Price Target to $75
JP Morgan analyst Hardik Parikh maintains Viking Therapeutics with a Overweight and lowers the price target from $80 to $75.
Morgan Stanley Maintains Overweight on Viking Therapeutics, Raises Price Target to $102
Morgan Stanley analyst Michael Ulz maintains Viking Therapeutics with a Overweight and raises the price target from $98 to $102.
Viking Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Viking Therapeutics, Inc. (Viking) (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...
Viking Therapeutics Announces Initiation of VK2735 Maintenance Dosing Clinical Trial in Patients with Obesity
Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...
أسهم ذات صلة
VICR
Vicor Corporation
SXTPW
60 Degrees Pharmaceuticals Inc. Warrant
ESRT
Empire State Realty Trust Inc.
MBOT
Microbot Medical Inc.
HFRO
Highland Opportunities and Income Fund Common Shares of Beneficial Interest
ابق على اطلاع
تعيين تنبيهات الأسعار، الحصول على تحديثات تحليل الذكاء الاصطناعي وأخبار السوق في الوقت الحقيقي.